Novelion Therapeutics Inc. is considering multiple strategic alternatives. In company news, Novelion Therapeutics shares gained nearly 32% after one of the company's largest shareholders urged the its board to consider all strategic options and "not simply choose the most expedient solution for debt-holders at the expense of the equity holders."